Rectiv Ointment
NDC Package 58914-301-85
Package Information
Rectiv (nitroglycerin) ointment is nitroglycerin ointment is used to treat moderate to severe pain caused by long-term tears in the lining of the anus (anal fissures). This formulation utilizes a ointment delivery system. Marketed by Allergan, Inc., this product is identified by NDC 58914-301 and is authorized under FDA application NDA021359.
Identification & Billing
- RxCUI: 1114466 - nitroglycerin 0.4 % Rectal Ointment
- RxCUI: 1114466 - nitroglycerin 0.004 MG/MG Rectal Ointment
- RxCUI: 1114466 - NTG 0.004 MG/MG Rectal Ointment
- RxCUI: 1114466 - TNG 0.004 MG/MG Rectal Ointment
- RxCUI: 1114470 - RECTIV 0.4 % Rectal Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58914 - Allergan, Inc.
- 58914-301 - Rectiv
- 58914-301-85 - 1 TUBE in 1 CARTON / 5 g in 1 TUBE
- 58914-301 - Rectiv
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (58914-301). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58914-301-85 identifies a specific commercial package of 1 tube in 1 carton / 5 g in 1 tube of Rectiv, a human prescription drug labeled by Allergan, Inc.. This ointment is formulated for rectal use and contains nitroglycerin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Allergan, Inc. on June 21, 2011.
What are the primary indications for this medication?
Nitroglycerin ointment is used to treat moderate to severe pain caused by long-term tears in the lining of the anus (anal fissures). This medication works by relaxing the muscles around the blood vessels which reduces pressure inside the anus and relieves pain. Nitroglycerin belongs to a class of drugs known as nitrates.
How is this Allergan, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58914030185. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.